Journal decision profile

Antimicrobial Agents and Chemotherapy

Medicine

Antimicrobial Agents and Chemotherapy's 2026 Journal Metrics Score is 4.0, ranking Q1 in Pharmacology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

American Society for MicrobiologyUnited StatespISSN 0066-4804eISSN 1098-6596
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
4.0

Journal Metrics Score 2026 · 2021–2024 window citedness 4.79.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

Free preview · no sign-in

Does your manuscript fit Antimicrobial Agents and Chemotherapy?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
4.02026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#9 / 3,494LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
24.3%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
1.53MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
—NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
482 / yr2021–2024 AVG
Field-normalized top 10% share24.3%

469 of 1,927 works · same type, year & subfield

Field-normalized top 1% share1.2%

23 works · same type, year & subfield

Median FWCI1.53×

Above field-year expectation

Source output rank#9

of 3,494 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.53, so its typical recent paper runs about 53% above its field benchmark.

What does Top 10% Share mean?

24.3% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

10212016
9562017
9262018
8562019
7672020
6952021
4272022
3692023
4372024
4382025

Recent work-type mix

1,927 OpenAlex works · 2021–2024

Article91.4%
Erratum2.1%
Letter1.7%
Review1.7%
Paratext1.5%
Editorial1.3%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Antimicrobial Agents and Chemotherapy publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Antibiotic Resistance in Bacteria389
Antifungal resistance and susceptibility189
Antibiotics Pharmacokinetics and Efficacy166
Tuberculosis Research and Epidemiology137
Malaria Research and Control114
Mycobacterium research and diagnosis90
Antimicrobial Resistance in Staphylococcus77
HIV/AIDS drug development and treatment47
SARS-CoV-2 and COVID-19 Research42
Bacteriophages and microbial interactions35
Methodology: OpenAlex snapshot 2026-11-12. FWCI, percentile badges, topics, and type mix use 1,927 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Molecular MedicineQ2
PharmacologyQ1
Infectious DiseasesQ1

Is Antimicrobial Agents and Chemotherapy a good journal?

Yes. A Q1 journal by citation data

Yes. By citation data, Antimicrobial Agents and Chemotherapy is a strong journal: it is Q1 in Pharmacology and 1 other subfield and ranks #804 of 6,272 Medicine journals by Journal Metrics Score (top 13%). Antimicrobial Agents and Chemotherapy's 2026 Journal Metrics Score is 4.0. OpenAlex classifies its papers in subfields including Molecular Medicine, Pharmacology, and Infectious Diseases, so check that your topic fits its scope.

Best quartile
Q1
Pharmacology
Rank in Medicine
#804 of 6,272
Top 13%
2026 Journal Metrics Score
4.0
Acceptance rate
Not published
By the journal or publisher
Papers published in 2025
437
OpenAlex works

Check before you submit

  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q1
Subfield Quartile
B2
CAS Block

Ranking and source check

#804
of 6,272 Medicine field journals
#801
among Q1 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
33,957
H-Index
356
Fully Open Access
No
Recent OA Works
29,666
Subject Areas
Molecular MedicinePharmacologyInfectious Diseases

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Antimicrobial Agents and Chemotherapy

  1. 1

    Check the scope

    OpenAlex classifies Antimicrobial Agents and Chemotherapy's papers in subfields including Molecular Medicine, Pharmacology, and Infectious Diseases. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Antimicrobial Agents and Chemotherapy homepage ↗
  3. 3

    Submit online

    Use the submit link in Antimicrobial Agents and Chemotherapy's author guidelines; American Society for Microbiology runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex has no article processing charge on record. Check the journal website for page charges or an optional open-access fee.

  5. 5

    Know what to expect

    Antimicrobial Agents and Chemotherapy does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Antimicrobial Agents and Chemotherapy

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Antimicrobial Agents and Chemotherapy

Is Antimicrobial Agents and Chemotherapy a good journal?

Yes. By citation data, Antimicrobial Agents and Chemotherapy is a strong journal: it is Q1 in Pharmacology and 1 other subfield and ranks #804 of 6,272 Medicine journals by Journal Metrics Score (top 13%). Antimicrobial Agents and Chemotherapy's 2026 Journal Metrics Score is 4.0. OpenAlex classifies its papers in subfields including Molecular Medicine, Pharmacology, and Infectious Diseases, so check that your topic fits its scope.

What is Antimicrobial Agents and Chemotherapy's Journal Metrics Score in 2026?

Antimicrobial Agents and Chemotherapy's 2026 Journal Metrics Score is 4.0, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Antimicrobial Agents and Chemotherapy?

We have not found an official acceptance rate published by Antimicrobial Agents and Chemotherapy or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Antimicrobial Agents and Chemotherapy's quartile and score with similar journals, or ask the editorial office.

What quartile is Antimicrobial Agents and Chemotherapy in?

Antimicrobial Agents and Chemotherapy's best quartile is Q1. By OpenAlex subfield: Q2 in Molecular Medicine; Q1 in Pharmacology; Q1 in Infectious Diseases. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Antimicrobial Agents and Chemotherapy will not match this score exactly. Compare journals using one source at a time.

Which journals are alternatives to Antimicrobial Agents and Chemotherapy?

Comparable journals include Annals of Clinical Microbiology and Antimicrobials, International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy, and Microbiology Spectrum. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Antimicrobial Agents and Chemotherapy?

Submit online through the link in Antimicrobial Agents and Chemotherapy's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.

Cite an article from this journal
Back to Search